| ［1］ |
Servitje O, Muniesa C, Benavente Y, et al. Primary cutaneous marginal zone B⁃cell lymphoma: response to treatment and disease⁃free survival in a series of 137 patients［J］. J Am Acad Dermatol, 2013,69（3）:357⁃365. doi: 10.1016/j.jaad.2013.04.047.
|
| ［2］ |
王琨, 张建华, 杨林花. 原发性皮肤边缘区B细胞淋巴瘤的研究进展［J］. 国际输血及血液学杂志, 2018,41（3）:251⁃255. doi: 10.3760/cma.j.issn.1673⁃419X.2018.03.012.
|
| ［3］ |
Guitart J, Deonizio J, Bloom T, et al. High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B⁃cell lymphomas［J］. JAMA Dermatol, 2014,150（4）:412⁃418. doi: 10.1001/jamadermatol.2013.9223.
|
| ［4］ |
Tsuji K, Suzuki D, Naito Y, et al. Primary cutaneous marginal zone B⁃cell lymphoma［J］. Eur J Dermatol, 2005,15（6）:480⁃483.
|
| ［5］ |
李百周, 孔蕴毅, 陆洪芬, 等. 原发性皮肤边缘区B细胞淋巴瘤组织病理特征和免疫表型分析［J］. 临床皮肤科杂志, 2007,36（12）:750⁃753. doi: 10.3969/j.issn.1000⁃4963.2007.12.004.
|
| ［6］ |
Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European organization for research and treatment of cancer［J］. Blood, 1997,90（1）:354⁃371.
|
| ［7］ |
张虹, 郭华, 农琳, 等. 原发性皮肤边缘区B细胞淋巴瘤临床病理特征［J］. 诊断病理学杂志, 2008,15（5）:373⁃377. doi: 10.3969/j.issn.1007⁃8096.2008.05.006.
|
| ［8］ |
Rijlaarsdam U, Bakels V, van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B⁃cell lymphomas and pseudo⁃B⁃cell lymphomas: differential diagnostic and pathogenetic aspects［J］. J Invest Dermatol, 1992,99（6）:749⁃754. doi: 10.1111/1523⁃1747.ep12614479.
|
| ［9］ |
Frings VG, Röding K, Strate A, et al. Paraproteinaemia in primary cutaneous marginal zone lymphoma［J］. Acta Derm Venereol, 2018,98（10）:956⁃962. doi: 10.2340/00015555⁃3016.
|
| ［10］ |
Brenner I, Roth S, Puppe B, et al. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression［J］. Mod Pathol, 2013,26（12）:1568⁃1576. doi: 10.1038/modpathol.2013.106.
|
| ［11］ |
Hamilton SN, Wai ES, Tan K, et al. Treatment and outcomes in patients with primary cutaneous B⁃cell lymphoma: the BC Cancer Agency experience［J］. Int J Radiat Oncol Biol Phys, 2013,87（4）:719⁃725. doi: 10.1016/j.ijrobp.2013.07.019.
|
| ［12］ |
Senff NJ, Noordijk EM, Kim YH, et al. European organization for research and treatment of cancer and international society for cutaneous lymphoma consensus recommendations for the management of cutaneous B⁃cell lymphomas［J］. Blood, 2008,112（5）:1600⁃1609. doi: 10.1182/blood⁃2008⁃04⁃152850.
|
| ［13］ |
Perry A, Vincent BJ, Parker SR. Intralesional corticosteroid therapy for primary cutaneous B⁃cell lymphoma［J］. Br J Dermatol, 2010,163（1）:223⁃225. doi: 10.1111/j.1365⁃2133.2010. 09798.x.
|
